Growth Hormone-Releasing Hormone Receptor Antagonists Inhibit Human Gastric Cancer Through Downregulation of PAK1–STAT3/NF-Κb Signaling
Growth hormone-releasing hormone receptor antagonists inhibit human gastric cancer through downregulation of PAK1–STAT3/NF-κB signaling Jinfeng Gana,1, Xiurong Kea,1, Jiali Jianga,1, Hongmei Donga,1, Zhimeng Yaoa, Yusheng Lina, Wan Lina, Xiao Wub, Shumei Yanc, Yixuan Zhuangb, Wai Kit Chud, Renzhi Caie,f,g,h,i, Xianyang Zhange,f,g,h,i, Herman S. Cheunge,f,j, Norman L. Blockk, Chi Pui Pangd,l, Andrew V. Schallye,f,g,h,i,k,2, and Hao Zhanga,b,m,2 aCancer Research Center, Shantou University Medical College, Shantou 515041, China; bTumor Tissue Bank, Affiliated Cancer Hospital of Shantou University Medical College, Shantou 515041, China; cDepartment of Pathology, Sun Yat-sen University Cancer Center, Guangzhou 510060, China; dDepartment of Ophthalmology & Visual Sciences, The Chinese University of Hong Kong, Hong Kong, China; eEndocrine, Polypeptide, and Cancer Institute, Veterans Affairs Medical Center, Miami, FL 33125; fSouth Florida Veterans Affairs Foundation for Research and Education, Miami, FL 33125; gDivision of Hematology and Oncology, Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL 33136; hDivision of Endocrinology, Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL 33136; iSylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL 33136; jDepartment of Biomedical Engineering, University of Miami, Coral Gables, FL 33146; kDepartment of Pathology, Miller School of Medicine, University of Miami, Miami, FL 33136; lJoint Shantou International Eye Center, Shantou University and The Chinese University of Hong Kong, Shantou 515041, China; and mDepartment of Biotherapy, Affiliated Cancer Hospital of Shantou University Medical College, Shantou 515041, China Contributed by Andrew V.
[Show full text]